Debbie Stewart, 54, from Kirkcudbright in Dumfries and Galloway, was diagnosed with a meningioma tumour in 2011 after taking Depo-Provera for 25 years. She only learned of the drug's link to brain tumours after reading about Tammy Croston's story in the Daily Record earlier this year and stopped taking it immediately.
Diagnosis and surgery
Debbie was prescribed the contraceptive injection in her 20s to manage difficult periods. She was diagnosed after suffering from headaches and severe pins and needles across her body. She underwent surgery to remove the mass 15 years ago but has been left suffering from blackouts and has been unable to work. Three more tumours have since been discovered growing inside her skull.
She told the Record: "When I read about Tammy's story in the Daily Record and how she believes her meningioma was caused by Depo-Provera, my stomach sank. I stopped taking it there and then. I took Depo-Provera for 25 years and I was never once told that it could cause brain tumours - I had no idea that this drug could be causing them. Even after I had surgery to remove my meninginoma, I continued to take it. The thought of it all now makes me feel sick."
Call for inquiry and MRI scans
Debbie said: "It has changed my life so much - I'm not allowed to work anymore and I've worked my whole life. It's horrible. I would never have taken Depo-Provera if I was ever told it could cause brain tumours. It's now looking likely that I'll need to get radiotherapy to shrink them all. This process has been devastating for me and many other women."
She has joined calls for a public inquiry into the drug and demanded annual MRI screening for women who have taken the birth control shot for more than a year. She said: "If the government doesn't investigate the use of this drug now, it will become a silent killer. If regular scans aren't brought in, women will be walking around with tumours that are going undetected. I dread to think of how many more victims there will be in ten years' time. Something has got to be done to either get this drug better regulated or get it off the market."
Official guidance and legal action
In September, Scotland's Chief Pharmaceutical Officer instructed all GPs to warn women about the tumour side effect after victims took their fight to Holyrood. The letter also instructed healthcare providers to review prescriptions every two years and to be aware of the actions they should take in the event that a tumour is suspected.
Tammy Croston said: "It's shocking that Debbie only made this correlation by reading my story in the Daily Record. It's amazing that the Daily Record continues to raise awareness, but it blows my mind that women are finding out about the meningioma link to Depo-Provera from a newspaper. Women shouldn't be making this correlation from the papers, they should be finding out about this firsthand from their GP. Women deserve to know the risks of the drug from the offset, not decades down the line and through the media."
Around 150 women are being represented by Thompsons Solicitors Scotland in their fight for damages against Pfizer. Patrick McGuire, senior partner at the law firm, said: "Debbie’s case is is deeply worrying as she was diagnosed with a tumour in 2011 but continued to take Depo-Provera for years afterwards without being given any warnings. After she was alerted to the dangers of this drug by the Daily Record’s journalism we stand ready to assist her as part of our law suit. All the ladies affected by this drug - as well as my legal team - continue to ask: Where is the leadership on this issue by both the Westminster and Scottish Governments? We need engagement from both our governments now as this scandal only continues to grow."
A proven link was made between Depo-Provera and meningiomas in 2014. The British Medical Journal found that women who used the drug were five times more likely to be diagnosed with the tumours than women who have never used the birth control. Around 5,000 women are currently suing Pfizer in the US, and further group actions are expanding across England and the rest of the UK.
A spokesperson for Pfizer said: "Patient safety is our top priority. We conduct rigorous and continuous monitoring of all our medicines, including assessments of reported adverse events, in collaboration with health authorities around the globe. We would encourage people to speak to their doctor, pharmacist or nurse if they have any concerns or experience any side effects."